Mark J Enyedy Immuno Gen, Inc. (IMGN) insider trading activity

Mark J Enyedy is CHIEF EXECUTIVE OFFICER of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 584,397 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Mark J Enyedy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2024	SELL Sale (or disposition) back to the issuer	-	584,397 Reduced 100.0%	0 Common Stock
Feb 05 2024	SELL Open market or private sale	$588,732 $29.28 p/Share	20,107 Reduced 3.33%	584,397 Common Stock
Feb 02 2024	BUY Exercise of conversion of derivative security	-	51,234 Added 7.81%	604,504 Common Stock
Aug 04 2023	SELL Open market or private sale	$16,831,053 $16.96 p/Share	992,397 Reduced 64.21%	553,270 Common Stock
Aug 04 2023	BUY Exercise of conversion of derivative security	$5,686,722 $5.15 p/Share	1,104,218 Added 41.67%	1,545,667 Common Stock
Aug 03 2023	SELL Open market or private sale	$16,942,200 $16.61 p/Share	1,020,000 Reduced 69.79%	441,449 Common Stock
Aug 03 2023	BUY Exercise of conversion of derivative security	$4,998,000 $4.9 p/Share	1,020,000 Added 41.11%	1,461,449 Common Stock
Aug 02 2023	SELL Open market or private sale	$17,713,794 $17.8 p/Share	995,157 Reduced 69.27%	441,449 Common Stock
Aug 02 2023	BUY Exercise of conversion of derivative security	$4,527,964 $4.55 p/Share	995,157 Added 40.92%	1,436,606 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$21,226 $4.05 p/Share	5,241 Added 1.17%	441,449 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$12,800 $3.83 p/Share	3,342 Added 0.76%	436,208 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	$21,246 $5.52 p/Share	3,849 Added 0.88%	432,866 Common Stock
Dec 22 2020	SELL Bona fide gift	-	10,000 Reduced 2.28%	429,017 Common Stock

Also insider at

LOGC

LogicBio Therapeutics, Inc. Healthcare

Director

BMRN

BIOMARIN PHARMACEUTICAL INC Healthcare

Director

MJE

Mark J Enyedy

CHIEF EXECUTIVE OFFICER

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Value

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to ImmunoGen, Inc.

Track Activities on IMGN

Account